Biofrontera Statistics

Total Valuation

Biofrontera has a market cap or net worth of $12.43 million. The enterprise value is $13.83 million.

Market Cap	12.43M
Enterprise Value	13.83M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026, after market close.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Biofrontera has 12.80 million shares outstanding. The number of shares has increased by 59.24% in one year.

Current Share Class	12.80M
Shares Outstanding	12.80M
Shares Change (YoY)	+59.24%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	9.72%
Owned by Institutions (%)	6.01%
Float	9.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	5.11
PS Ratio	0.29
Forward PS	0.27
PB Ratio	1.90
P/TBV Ratio	3.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.27.

Current Ratio	1.20
Quick Ratio	0.99
Debt / Equity	1.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-22.78

Financial Efficiency

Return on equity (ROE) is -339.04% and return on invested capital (ROIC) is -70.12%.

Return on Equity (ROE)	-339.04%
Return on Assets (ROA)	-32.41%
Return on Invested Capital (ROIC)	-70.12%
Return on Capital Employed (ROCE)	-77.39%
Weighted Average Cost of Capital (WACC)	7.34%
Revenue Per Employee	$459,585
Profits Per Employee	-$117,926
Employee Count	94
Asset Turnover	2.09
Inventory Turnover	2.53

Taxes

In the past 12 months, Biofrontera has paid $26,000 in taxes.

Income Tax	26,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.53% in the last 52 weeks. The beta is 0.85, so Biofrontera's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+55.53%
50-Day Moving Average	0.99
200-Day Moving Average	0.92
Relative Strength Index (RSI)	51.10
Average Volume (20 Days)	231,957

Short Selling Information

The latest short interest is 69,336, so 0.54% of the outstanding shares have been sold short.

Short Interest	69,336
Short Previous Month	84,396
Short % of Shares Out	0.54%
Short % of Float	0.76%
Short Ratio (days to cover)	0.35

Income Statement

In the last 12 months, Biofrontera had revenue of $43.20 million and -$11.09 million in losses. Loss per share was -$1.02.

Revenue	43.20M
Gross Profit	33.39M
Operating Income	-10.73M
Pretax Income	-11.06M
Net Income	-11.09M
EBITDA	-10.57M
EBIT	-10.73M
Loss Per Share	-$1.02

Full Income Statement

Balance Sheet

The company has $6.33 million in cash and $7.72 million in debt, giving a net cash position of -$1.40 million or -$0.11 per share.

Cash & Cash Equivalents	6.33M
Total Debt	7.72M
Net Cash	-1.40M
Net Cash Per Share	-$0.11
Equity (Book Value)	6.07M
Book Value Per Share	0.51
Working Capital	2.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.31 million and capital expenditures -$4,000, giving a free cash flow of -$9.32 million.

Operating Cash Flow	-9.31M
Capital Expenditures	-4,000
Depreciation & Amortization	164,000
Net Borrowing	n/a
Free Cash Flow	-9.32M
FCF Per Share	-$0.73

Full Cash Flow Statement

Margins

Gross margin is 77.29%, with operating and profit margins of -24.84% and -25.66%.

Gross Margin	77.29%
Operating Margin	-24.84%
Pretax Margin	-25.60%
Profit Margin	-25.66%
EBITDA Margin	-24.46%
EBIT Margin	-24.84%
FCF Margin	n/a

Dividends & Yields

Biofrontera does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-59.24%
Shareholder Yield	-59.24%
Earnings Yield	-89.16%
FCF Yield	-74.95%

Analyst Forecast

The average price target for Biofrontera is $5.88, which is 505.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.88
Price Target Difference	505.56%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	14.89%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 5, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Jul 5, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Biofrontera has an Altman Z-Score of -6.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.79
Piotroski F-Score	3